Product Information
MEMANTINE HCL 10 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.0664 per EA under NDC 00527122206. Its NADAC has been published 328 times since Aug 8, 2018.
FDA first approved this application on Nov 10, 2016.
Strength
10 mg/1
Manufacturer
Lannett Company Inc.NDC
00527122206
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207236FDA Approved
11/10/2016
On Market Since
11/10/2016
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 10 MG TABLET has been published 328 times since Aug 8, 2018, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0664 per EA |
|---|---|
| All-time high | $0.1359 (Aug 15, 2018) |
| All-time low | $0.0592 (May 22, 2024) |
| Median price | $0.0897 |
| Average price | $0.0876 |
| Largest weekly change | -27.0% (Sep 23, 2020) |
| Weeks tracked | 328 |
| Tracking since | Aug 8, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-9.7%
5Y
-27.7%
All
-51.2%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 10 MG TABLET, manufactured by Lannett Company Inc., is $0.0664 per EA (NDC 00527122206), effective Nov 13, 2024.
How has the price of MEMANTINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 10 MG TABLET has declined 51.2%. It has been tracked across 328 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 10 MG TABLET?
Since Aug 8, 2018, the NADAC for MEMANTINE HCL 10 MG TABLET has ranged from a low of $0.0592 (May 22, 2024) to a high of $0.1359 (Aug 15, 2018), with a median of $0.0897 per EA.
Are there cheaper alternatives to MEMANTINE HCL 10 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEMANTINE HCL 10 MG TABLET, is $0.0630 per EA — about 5% below MEMANTINE HCL 10 MG TABLET.
Who manufactures MEMANTINE HCL 10 MG TABLET?
MEMANTINE HCL 10 MG TABLET (NDC 00527122206) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.